Delhi High Court

Conditional Permission to Liquidate Existing Stock Subject to Deposit of Sale Proceeds Pending Disposal of Injunction Challenge

Celsius Healthcare Pvt Ltd vs Dwd Pharmaceuticals Ltd

Delhi High CourtJUDGMENT: July 21, 20262 MIN READSOURCE JUDGMENT
THE ORIGINAL LAWLENS SUMMARY
01

Facts

The Appellant challenged an ex-parte ad-interim injunction order dated June 5, 2026, passed by a learned Single Judge in I.A. No. 15975/2026.

Source reference: para. 1

The Single Judge had restrained the Appellant from manufacturing or selling goods under the marks "DIZEST," "CELSIUSDIZEST," or "DYZEST," finding them deceptively similar to the Respondent's "ZEST" family of marks.

Source reference: para. 1

During the appeal, the Appellant expressed intent to file a vacation of stay under Order XXXIX Rule 4 of the CPC but sought permission to liquidate existing stock valued at approximately ₹27.91 Lakhs.

Source reference: para. 2

The Respondent consented to this sale provided the proceeds were secured by the Court.

Source reference: para. 3
02

Issues

1. Whether the Appellant should be permitted to dispose of existing inventory bearing the impugned trademarks pending the final adjudication of the injunction application?

Source reference: para. 4
03

Law Applied

The court exercised its appellate jurisdiction under the Code of Civil Procedure, 1908 (CPC), specifically considering the balance of equities inherent in Order XXXIX Rules 1, 2, and 4.

Source reference: paras. 4-8

The court relied on the principle of "equitable interim relief," allowing a party to mitigate losses through a court-monitored sale where the opposing party provides consent.

Source reference: para. 3
04

Reasoning

The court did not delve into the merits of the trademark infringement or passing off claims, as the Appellant elected to pursue a vacation of the injunction before the Single Judge.

Source reference: para. 2, 9

By recording the Respondent's "no objection" to the sale of the inventory—contingent upon the deposit of sale proceeds—the court created a safeguard for both parties.

Source reference: para. 3

The court determined that allowing the sale of unit-specific batches (as detailed in the Appellant's affidavit) by October 31, 2026, would prevent the total loss of the goods' value while ensuring the disputed revenue remains within the court's jurisdiction to satisfy any future decree.

Source reference: para. 4-7
05

Holding

The Court disposed of the appeal by granting the Appellant permission to sell the existing stock of "DIZEST/CELSIUSDIZEST" products on or before October 31, 2026.

The Appellant was directed to deposit 50% of the sale proceeds with the Registrar General of the High Court by November 15, 2026, which is to be kept in an interest-bearing FDR.

Source reference: paras. 5, 7

The Appellant must file an affidavit of sale/balance stock by the same date.

Source reference: para. 6

The Court clarified that this arrangement is without prejudice to the parties' rights in the main suit and the Appellant was granted liberty to file an application under Order XXXIX Rule 4 CPC before the Single Judge.

Source reference: para. 8, 9
Delhi High Court

Original Court PDF

Celsius Healthcare Pvt LtdvsDwd Pharmaceuticals Ltd

Delhi High Court · July 21, 2026

Click to open original judgment

Original judgment, available to read, download and summarize on LawLens.in

Click to open original judgment